CMA1 and Cirrhosis: Although not evaluated in patients with NASH, both chymase and angiotensin II-forming activities were significantly augmented in fibrotic regions of livers from patients with cirrhosis, and significant correlations among chymase, angiotensin II-forming activity and hepatic fibrosis were observed (Komeda et al., 2008).